List of Tables
Table 1. Global Generalized Anxiety Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of SSRIs
Table 3. Key Players of SNRIs
Table 4. Key Players of Others
Table 5. Global Generalized Anxiety Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Generalized Anxiety Disorder Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Generalized Anxiety Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Generalized Anxiety Disorder Treatment Market Share by Region (2020-2025)
Table 9. Global Generalized Anxiety Disorder Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Generalized Anxiety Disorder Treatment Market Share by Region (2026-2031)
Table 11. Generalized Anxiety Disorder Treatment Market Trends
Table 12. Generalized Anxiety Disorder Treatment Market Drivers
Table 13. Generalized Anxiety Disorder Treatment Market Challenges
Table 14. Generalized Anxiety Disorder Treatment Market Restraints
Table 15. Global Generalized Anxiety Disorder Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Generalized Anxiety Disorder Treatment Market Share by Players (2020-2025)
Table 17. Global Top Generalized Anxiety Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generalized Anxiety Disorder Treatment as of 2024)
Table 18. Ranking of Global Top Generalized Anxiety Disorder Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Generalized Anxiety Disorder Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Generalized Anxiety Disorder Treatment, Headquarters and Area Served
Table 21. Global Key Players of Generalized Anxiety Disorder Treatment, Product and Application
Table 22. Global Key Players of Generalized Anxiety Disorder Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Generalized Anxiety Disorder Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Generalized Anxiety Disorder Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Generalized Anxiety Disorder Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Generalized Anxiety Disorder Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Generalized Anxiety Disorder Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Generalized Anxiety Disorder Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Generalized Anxiety Disorder Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Generalized Anxiety Disorder Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Generalized Anxiety Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Generalized Anxiety Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Generalized Anxiety Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Generalized Anxiety Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Generalized Anxiety Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Generalized Anxiety Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Generalized Anxiety Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Generalized Anxiety Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Generalized Anxiety Disorder Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Generalized Anxiety Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Generalized Anxiety Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Generalized Anxiety Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Generalized Anxiety Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Generalized Anxiety Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Generalized Anxiety Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Intellipharmaceutics Company Details
Table 48. Intellipharmaceutics Business Overview
Table 49. Intellipharmaceutics Generalized Anxiety Disorder Treatment Product
Table 50. Intellipharmaceutics Revenue in Generalized Anxiety Disorder Treatment Business (2020-2025) & (US$ Million)
Table 51. Intellipharmaceutics Recent Development
Table 52. Pfizer Company Details
Table 53. Pfizer Business Overview
Table 54. Pfizer Generalized Anxiety Disorder Treatment Product
Table 55. Pfizer Revenue in Generalized Anxiety Disorder Treatment Business (2020-2025) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Eli Lilly Company Details
Table 58. Eli Lilly Business Overview
Table 59. Eli Lilly Generalized Anxiety Disorder Treatment Product
Table 60. Eli Lilly Revenue in Generalized Anxiety Disorder Treatment Business (2020-2025) & (US$ Million)
Table 61. Eli Lilly Recent Development
Table 62. Astrazeneca Company Details
Table 63. Astrazeneca Business Overview
Table 64. Astrazeneca Generalized Anxiety Disorder Treatment Product
Table 65. Astrazeneca Revenue in Generalized Anxiety Disorder Treatment Business (2020-2025) & (US$ Million)
Table 66. Astrazeneca Recent Development
Table 67. Lundbeck Company Details
Table 68. Lundbeck Business Overview
Table 69. Lundbeck Generalized Anxiety Disorder Treatment Product
Table 70. Lundbeck Revenue in Generalized Anxiety Disorder Treatment Business (2020-2025) & (US$ Million)
Table 71. Lundbeck Recent Development
Table 72. Allergan Company Details
Table 73. Allergan Business Overview
Table 74. Allergan Generalized Anxiety Disorder Treatment Product
Table 75. Allergan Revenue in Generalized Anxiety Disorder Treatment Business (2020-2025) & (US$ Million)
Table 76. Allergan Recent Development
Table 77. GSK Company Details
Table 78. GSK Business Overview
Table 79. GSK Generalized Anxiety Disorder Treatment Product
Table 80. GSK Revenue in Generalized Anxiety Disorder Treatment Business (2020-2025) & (US$ Million)
Table 81. GSK Recent Development
Table 82. Otsuka Pharmaceutical Company Details
Table 83. Otsuka Pharmaceutical Business Overview
Table 84. Otsuka Pharmaceutical Generalized Anxiety Disorder Treatment Product
Table 85. Otsuka Pharmaceutical Revenue in Generalized Anxiety Disorder Treatment Business (2020-2025) & (US$ Million)
Table 86. Otsuka Pharmaceutical Recent Development
Table 87. Takeda Company Details
Table 88. Takeda Business Overview
Table 89. Takeda Generalized Anxiety Disorder Treatment Product
Table 90. Takeda Revenue in Generalized Anxiety Disorder Treatment Business (2020-2025) & (US$ Million)
Table 91. Takeda Recent Development
Table 92. NHU Group Company Details
Table 93. NHU Group Business Overview
Table 94. NHU Group Generalized Anxiety Disorder Treatment Product
Table 95. NHU Group Revenue in Generalized Anxiety Disorder Treatment Business (2020-2025) & (US$ Million)
Table 96. NHU Group Recent Development
Table 97. Shionogi Company Details
Table 98. Shionogi Business Overview
Table 99. Shionogi Generalized Anxiety Disorder Treatment Product
Table 100. Shionogi Revenue in Generalized Anxiety Disorder Treatment Business (2020-2025) & (US$ Million)
Table 101. Shionogi Recent Development
Table 102. APOTEX Company Details
Table 103. APOTEX Business Overview
Table 104. APOTEX Generalized Anxiety Disorder Treatment Product
Table 105. APOTEX Revenue in Generalized Anxiety Disorder Treatment Business (2020-2025) & (US$ Million)
Table 106. APOTEX Recent Development
Table 107. Kanghong Pharma Company Details
Table 108. Kanghong Pharma Business Overview
Table 109. Kanghong Pharma Generalized Anxiety Disorder Treatment Product
Table 110. Kanghong Pharma Revenue in Generalized Anxiety Disorder Treatment Business (2020-2025) & (US$ Million)
Table 111. Kanghong Pharma Recent Development
Table 112. HUAHAI Company Details
Table 113. HUAHAI Business Overview
Table 114. HUAHAI Generalized Anxiety Disorder Treatment Product
Table 115. HUAHAI Revenue in Generalized Anxiety Disorder Treatment Business (2020-2025) & (US$ Million)
Table 116. HUAHAI Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report
List of Figures
Figure 1. Generalized Anxiety Disorder Treatment Picture
Figure 2. Global Generalized Anxiety Disorder Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Generalized Anxiety Disorder Treatment Market Share by Type: 2024 VS 2031
Figure 4. SSRIs Features
Figure 5. SNRIs Features
Figure 6. Others Features
Figure 7. Global Generalized Anxiety Disorder Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Generalized Anxiety Disorder Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Generalized Anxiety Disorder Treatment Report Years Considered
Figure 13. Global Generalized Anxiety Disorder Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Generalized Anxiety Disorder Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Generalized Anxiety Disorder Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Generalized Anxiety Disorder Treatment Market Share by Players in 2024
Figure 17. Global Top Generalized Anxiety Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generalized Anxiety Disorder Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Generalized Anxiety Disorder Treatment Revenue in 2024
Figure 19. North America Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Generalized Anxiety Disorder Treatment Market Share by Country (2020-2031)
Figure 21. United States Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Generalized Anxiety Disorder Treatment Market Share by Country (2020-2031)
Figure 25. Germany Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Generalized Anxiety Disorder Treatment Market Share by Region (2020-2031)
Figure 33. China Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Generalized Anxiety Disorder Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Generalized Anxiety Disorder Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Generalized Anxiety Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Intellipharmaceutics Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2020-2025)
Figure 50. Eli Lilly Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2020-2025)
Figure 51. Astrazeneca Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2020-2025)
Figure 52. Lundbeck Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2020-2025)
Figure 53. Allergan Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2020-2025)
Figure 54. GSK Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2020-2025)
Figure 55. Otsuka Pharmaceutical Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2020-2025)
Figure 56. Takeda Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2020-2025)
Figure 57. NHU Group Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2020-2025)
Figure 58. Shionogi Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2020-2025)
Figure 59. APOTEX Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2020-2025)
Figure 60. Kanghong Pharma Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2020-2025)
Figure 61. HUAHAI Revenue Growth Rate in Generalized Anxiety Disorder Treatment Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
